Enhabit is a medical care facility company located in Alabama, United States, which is part of the Healthcare sector, and is traded under the ticker EHAB on the NYSE exchange.
Enhabit stock last closed at $13.70, up 2.85% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Medical Care Facilities industry by N/A percentage points. Enhabit stock is currently +17.6% from its 52-week low of $11.65, and -41.73% from its 52-week high of $23.51.
There are currently 49.62M shares of EHAB outstanding. The market cap of EHAB is $679.77M. In the last 24 hours, 444,295 EHAB shares were traded.
You will need an online brokerage account in order to access the NYSE market and buy EHAB stock.
In our opinion, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your share purchase by creating an account with eToro now.
Open eToro AccountNow that you've selected the right brokerage, it's time to fill out some personal info so you are able to buy EHAB stock today.
Now that you've filled out your info on apps for stock market, you need to deposit funds:
Check out the video below for more details transferring funds into your brokerage account.
Once you have selected the best place to buy Enhabit stock, it's very important to research their stock prior to buying, so you actually comprehend the risk as well as the opportunity.
WallStreetZen was built to help average investors do more accurate fundamental analysis in less time.
You can view all of the due diligence checks on EHAB's stock page.
You can use many financial metrics, analyses, models, and charts to gauge EHAB's true value.
Using relative valuations measures:
You can access additional valuation research on EHAB's stock here.
Out of 10 sell side analysts who give ratings on EHAB, the consensus analyst rating on EHAB is a Hold
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
Jamie Perse, a top 24% analyst from Goldman Sachs initiates coverage on EHAB with a hold rating and announces their EHAB price target of $15.00, on Mar 16, 2023.
Jason Cassorla, a bottom 14% analyst from Citigroup maintains EHAB with a hold rating and raises their EHAB price target from $16.00 to $18.00, on Feb 17, 2023.
Jonathan Yong, a bottom 8% analyst from Credit Suisse reiterates EHAB with a hold rating and maintains their EHAB price target from $15.00 to $15.00, on Feb 16, 2023.
Larry Solow, a bottom 31% analyst from CJS Securities initiates coverage on EHAB with a hold rating and announces their EHAB price target of $18.00, on Dec 13, 2022.
Andrew Mok, a bottom 15% analyst from UBS initiates coverage on EHAB with a strong sell rating and announces their EHAB price target of $12.00, on Dec 8, 2022.
You can dive deeper into what analysts are projecting on the Enhabit stock forecast page.
In the past 12 months, insiders at EHAB have bought more shares than they have sold.
Jeffrey Bolton, Director of EHAB, was the latest EHAB insider to buy. They bought $12,690.00 worth of EHAB stock on Nov 18, 2022.
Get more info about who owns EHAB shares here.
No, Enhabit doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
There are two main types of orders:
Hit the Open Trade button and your broker will place your order.
If you want more assistance investing in stocks on eToro, click the helpful video below:
Now that you own some EHAB shares, you'll want to keep up with your investment.
Create a watchlist to get the latest updates about your EHAB stock.
To summarize, here are the 6 steps for buying Enhabit stock:
If you require a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get notifications regarding your new investment in Enhabit, add EHAB to your watchlist by clicking the button below.